BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 29349754)

  • 21. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
    Fatum M; McVeigh E; Child T
    Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
    Decanter C; Robin G
    Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fertility preservation in breast cancer patients.
    Rodgers RJ
    Minerva Ginecol; 2019 Jun; 71(3):196-206. PubMed ID: 31089071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.
    Kim SY; Kim SK; Lee JR; Woodruff TK
    J Gynecol Oncol; 2016 Mar; 27(2):e22. PubMed ID: 26768785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature.
    Carneiro MM; Cota AM; Amaral MC; Pedrosa ML; Martins BO; Furtado MH; Lamaita RM; Ferreira MCF
    JBRA Assist Reprod; 2018 Sep; 22(3):244-252. PubMed ID: 29932615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fertility preservation and preimplantation genetic assessment for women with breast cancer.
    Sciorio R; Anderson RA
    Cryobiology; 2020 Feb; 92():1-8. PubMed ID: 31863734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oocyte and embryo cryopreservation before gonadotoxic treatments: Principles of safe ovarian stimulation, a systematic review.
    Ozcan MC; Snegovskikh V; Adamson GD
    Womens Health (Lond); 2022; 18():17455065221074886. PubMed ID: 35130799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
    Lambertini M; Goldrat O; Ferreira AR; Dechene J; Azim HA; Desir J; Delbaere A; t'Kint de Roodenbeke MD; de Azambuja E; Ignatiadis M; Demeestere I
    Ann Oncol; 2018 Jan; 29(1):237-243. PubMed ID: 29045555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New trends in female fertility preservation: in vitro maturation of oocytes.
    Berwanger AL; Finet A; El Hachem H; le Parco S; Hesters L; Grynberg M
    Future Oncol; 2012 Dec; 8(12):1567-73. PubMed ID: 23231518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in fertility preservation.
    Dolmans MM; Manavella DD
    J Obstet Gynaecol Res; 2019 Feb; 45(2):266-279. PubMed ID: 30246274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility preservation for female cancer patients.
    Harada M; Osuga Y
    Int J Clin Oncol; 2019 Jan; 24(1):28-33. PubMed ID: 29502284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IVF for fertility preservation in breast cancer patients--efficacy and safety issues.
    Shapira M; Raanani H; Meirow D
    J Assist Reprod Genet; 2015 Aug; 32(8):1171-8. PubMed ID: 26126877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
    Lambertini M; Del Mastro L; Viglietti G; Pondé NF; Solinas C; de Azambuja E
    Curr Treat Options Oncol; 2017 Jan; 18(1):4. PubMed ID: 28185173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women.
    von Wolff M; Dittrich R; Liebenthron J; Nawroth F; Schüring AN; Bruckner T; Germeyer A
    Reprod Biomed Online; 2015 Nov; 31(5):605-12. PubMed ID: 26380870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility Preservation and Sexual Health After Cancer Therapy.
    Pereira N; Schattman GL
    J Oncol Pract; 2017 Oct; 13(10):643-651. PubMed ID: 28809602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oocyte/embryo cryopreservation before chemotherapy for breast cancer].
    Decanter C; Gligorov J
    Gynecol Obstet Fertil; 2011 Sep; 39(9):501-3. PubMed ID: 21835668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
    Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
    Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mature Oocyte Cryopreservation for Fertility Preservation.
    Liang T; Motan T
    Adv Exp Med Biol; 2016; 951():155-161. PubMed ID: 27837562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.